Effect of sodium thiosulphate and cis-diamminedichloroplatinum on FADU tumour cells in nude mice

Journal of Otolaryngology

Volumn 34, Issue 6, 2005, Pages 371-373

  Viallet, Norbert R ^a   Blakley, Brian W ^a   Begleiter, Asher ^b   Leith, Marsha K ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cancer; Chemotherapy; Cisplatin; Hearing; Ototoxicity

Indexed keywords

CISPLATIN; CREATININE; PROTECTIVE AGENT; SODIUM CHLORIDE; SODIUM THIOSULFATE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MOUSE; NEPHROTOXICITY; NONHUMAN; NUDE MOUSE; OTOTOXICITY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; FEMALE; HEARING LOSS; HUMANS; KIDNEY DISEASES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RANDOM ALLOCATION; STOMACH NEOPLASMS; THIOSULFATES; TREATMENT OUTCOME;

EID: 30944451796     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2005.34602     Document Type: Article

References (24)

1. Church MW, Kaltenbach JA, Blakley BW, Burgio DL. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear Res 1995;86:195-203.
2. Kaltenbach JA, Church MW, Blakley BW, et al. Comparison of five agents in protecting the cochlea against the oto-toxic effects of cisplatin in the hamster. Otol Head Neck Surg 1997;117:493-500.
3. Rybak LP, Somani S. Ototoxicity. Amelioration by protective agents. Ann N Y Acad Sci 1999;884:143-51.
4. Rybak LP, Husain K, Morris C, et al. Effects of protective agents against cisplatin ototoxicity. Am J Otol 2000;21:513-20.
5. Pfeifle CE, Howell SB, Felthouse RD, et al. High-dose cisplatin with sodium thiosulfate protection. J Clin Oncol 1985;3:237-44.
6. Madasu R, Ruckenstein MJ, Leake F, et al. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1997;123:978-81.
7. Leitao DJ, Blakley BW. Quantification of sodium thiosulphate protection on cisplatin-induced toxicities. J Otolaryngol 2003;32:146-50.
8. Abe R, Akiyoshi T, Baba T. Inactivation of cis-diamminedichloroplatinum (II) in blood by sodium thiosulfate. Oncology 1990;47:65-9.
9. Abe R, Akiyoshi T, Baba T. 'Two-route chemotherapy' using cisplatin and its neutralizing agent, sodium thiosulfate, for intraperitoneal cancer. Oncology 1990;47:422-6.
10. Inoue M, Shimizu C, Shimizu H, Tanizawa O. Neutralizing effect of sodium thiosulfate on antitumor efficacy of cisplatin for human carcinoma xenografts in nude mice. Gynecol Oncol 1991;40:34-7.
11. Viale M, Zhang JG, Pastrone I, et al. Cisplatin combined with tiopronin or sodium thiosulfate: cytotoxicity in vitro and antitumor activity in vivo. Anticancer Drugs 1999;10:419-28.
12. Robbins KT, Vicario D, Seagren S, et al. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 1994;168:419-22.
13. Los G, Blommaert A, Barton R, et al. Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation. Cancer Chemother Pharmacol 1995;37:150-4.
14. Fujii T, Saito D, Yoshida S, et a. [The influence of sodium thiosulfate on the antitumor effect of cisplatin in human 7 gastric cancer cell lines]. Gan To Kagaku Ryoho 1988;15:3227-2.
15. Kovacs AF, Cinatl J Jr. In vitro cytotoxic dose-relation of cisplatin and sodium thiosulphate in human tongue and oesophageal squamous carcinoma cell lines. J Craniomaxillofac Surg 2002;30:54-8.
16. Blakley BW, Cohen JI, Doolittle ND, et al. Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001. Laryngoscope 2002;112:1997-2001.
17. Elferink F, van der Vijgh WJ, Klein I, Pinedo HM. Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding. Clin Chem 1986;32:641-5.
18. Uozumi J, Ishizawa M, Iwamoto Y, Baba T. Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity. Cancer Chemother Pharmacol 1984;13:82-5.
19. Viallet NR, Blakley BB, Begleiter A, Leith MK. Sodium thiosulfate impairs the cytotoxic effects of cisplatin on FADU cells in culture. [Submitted]
20. Wagner T, Kreft B, Bohlmann G, Schwieder G. Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin. J Cancer Res Clin Oncol 1988;114:497-501.
21. Andrews P, Wung W, Howell S. A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate. Anal Biochem 1984;143:46-56.
22. Muldoon LL, Pagel MA, Kroll RA, et al. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res 2000;6:309-15.
23. Doolittle ND, Muldoon LL, Brummett RE, et al. Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors. Clin Cancer Res 2001;7:493-500.
24. Ladas EJ, Jacobson JS, Kennedy DD, et al. Antioxidants and cancer therapy: a systematic review. J Clin Oncol 2004;22:517-28.